Adverse events following diphtheria, pertussis and tetanus vaccinations and factors associated with severity

Revista de Saude Publica

Volumn 41, Issue 6, 2007, Pages 1032-1041

  de Freitas, Fabiana Ramos Martin ^a   Sato, Helena Keico ^b   Aranda, Clélia Maria Sarmento de Souza ^b   Arantes, Benedito Antonio Figueiredo ^b   Pacheco, Maria Aparecida ^b   Waldman, Eliseu Alves ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Secretaria de Estado da Saude de Sao Paulo   (Brazil)

Author keywords

Cross sectional studies; Diphtheria tetanus pertussis vaccine, adverse effects; Epidemiologic surveillance; Vaccines, adverse events following vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ARTICLE; BRAZIL; CHILD; CROSS-SECTIONAL STUDY; DIPHTHERIA; DRUG CONTRAINDICATION; DRUG SURVEILLANCE PROGRAM; FEMALE; HEALTH SURVEY; HUMAN; INFANT; MALE; PERTUSSIS; PRESCHOOL CHILD; RISK; STANDARD; STATISTICAL MODEL; STATISTICS; TETANUS; VACCINATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; BRAZIL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIPHTHERIA; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HUMANS; INFANT; LOGISTIC MODELS; MALE; ODDS RATIO; POPULATION SURVEILLANCE; TETANUS; VACCINATION; WHOOPING COUGH;

EID: 38049170907     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-89102007000600019     Document Type: Article

References (24)

1. Baraff LJ, Cody CL, Cherry JD. DPT-associated reactions: an analysis by injection site, manufacturer, prior reactions and dose. Pediatrics. 1984;73(1):31-6.
2. Baraff LJ, Manclark CR, Cherry JD, Christenson P, Marcy MS. Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain. Pediatr Infect Dis J. 1989;8(8):502-7.
3. Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP, et al. The risk of seizures after receipt of whole-cell pertussis or measles, mumps and rubella vaccine. N Engl J Med. 2001;345(9):656-61.
4. Begg N, Miller E. Role of epidemiology in vaccine policy. Vaccine. 1990;8(3):180-9.
5. Blumberg DA, Lewis K, Mink CM, Christenson PD, Chatfield P. Cherry JD. Severe reactions associated with diphtheria-tetanus-pertussis vaccine: detailed study of children with seizures, hypotonic-hyporesponsive episodes, high fevers and persistent crying. Pediatrics. 1993;91(6):1158-65.
6. Bonhoeffer J, Kohl K, Chen R, Duclos P, Heijbel H, Heininger U, et al. The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). Vaccine. 2002;21(3-4):298-302.
7. Braun MM, Ellenberg SS. Descriptive epidemiology of adverse events after immunization: reports to the Vaccine Adverse Events Reporting System (VAERS), 1991-1994. J Pediatr. 1997;131(4):529-35.
8. Centers for Disease Control and Prevention. Surveillance for Safety after Immunization: Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2001. MMWR. 2003;52(No.SS-1).
9. Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, et al. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pedriatrics. 1997;99(6):765-73.
10. Clayton D, Hills M. Statistical Models in Epidemiology. Oxford: Oxford Science Publications; 1996.
11. Cody CL, Barraff LJ, Cherry JD, Marcy SM, Manclark CR. Nature and rates of adverse reactions associated with DPT and DT immunizations in infants and children. Pediatrics. 1981;68(5):650-60.
12. Ellenberg SS, Chen RT. The complicated task of monitoring vaccine safety. Public Health Rep. 1997;112(1):10-20.
13. Galazka AM, Robertson SE, Oblapenco GP. Resurgence of diphteria. Eur J Epidemiol. 1995;11(1):95-105.
14. Gangarosa EJ, Galazka AM, Wolfe CR, Phillips LM, Gangarosa RE, Miller E, et al. Impact of anti-vaccine movements on Pertussis control: the untold story. Lancet. 1998;351(9099):356-61.
15. Goodwin H, Nash M, Gold M, Heath TC, Burgess MA. Vaccination of children following a previous hypotonic-hyporesponsive episode. J Paediatr Child Health. 1999;35(6):549-52.
16. Heininger U. The success of immunization - shoveling its own grave? Vaccine. 2004;22(15-16):2071-2.
17. Lawrence G, Menzies R, Burgess M, McIntyre P, Word N, Boyd I, et al. Surveillarice of adverse events following immunization: Australia, 2000-2002. Commun Dis Intell. 2003;27(3):307-23.
18. Livengood JR, Mullen JR, White JW, Brink EW, Orenstein WA. Family history of convulsions and use of pertussis vaccine. J Pediatr. 1989;115(4):527-31.
19. Rosenthal S, Chen R, Hadler S. The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine: a postmarketing assessment. Arch Pediatr Adolesc Med. 1996;150(5):457-60.
20. Singleton JA, Lloyd JC, Mootrey GT, Salive ME, Chen RT. An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group. Vaccine. 1999;17(22):2908-17.
21. Stetler HC, Mullen JR, Brennan JP, Livengood JR, Orentein WA, Hinman AR. Monitoring system for adverse events following immunization. Vaccine. 1987;5(3):169-74.
22. Tozzi AE. Field evaluation of vaccine safety. Vaccine. 2004; 22(15-16):2091-5.
23. Ward BJ. Vaccine adverse events in the new millennium: is there a reason for concern? Bull World Health Organ. 2000;78(2):205-15.
24. Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, et al. Surveillance for Safety after Immunization: Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2001. MMWR Surveill Summ. 2003;52(1):1-24.